Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-055751
Filing Date
2021-02-25
Accepted
2021-02-25 07:46:55
Documents
74
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d106177d10k.htm   iXBRL 10-K 2143847
2 EX-10.9 d106177dex109.htm EX-10.9 62273
3 EX-23.1 d106177dex231.htm EX-23.1 4326
4 EX-31.1 d106177dex311.htm EX-31.1 6262
5 EX-31.2 d106177dex312.htm EX-31.2 6381
6 EX-32.1 d106177dex321.htm EX-32.1 4321
12 GRAPHIC g106177g94r19.jpg GRAPHIC 116942
  Complete submission text file 0001193125-21-055751.txt   8796822

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA itci-20201231.xsd EX-101.SCH 48569
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20201231_cal.xml EX-101.CAL 54481
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20201231_def.xml EX-101.DEF 294009
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20201231_lab.xml EX-101.LAB 469603
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20201231_pre.xml EX-101.PRE 423188
13 EXTRACTED XBRL INSTANCE DOCUMENT d106177d10k_htm.xml XML 1418936
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 21676451
SIC: 2834 Pharmaceutical Preparations